Company intelligence / Profile preview

Waymark

San Francisco, California, United Stateswaymark.com ↗

Ownership: Private
Development stage: Other

Overview

Waymark has demonstrated significant clinical impact in peer-reviewed studies, including a 23% reduction in all-cause emergency department and hospital visits among rising-risk Medicaid patients compared to controls, a 63% rate of clinical and social goal completion, and machine learning tools with up to 90% accuracy in predicting avoidable ED/hospital visits.

Therapeutic areas: PsychiatryOther
Industry: Non-Academic Healthcare

Partnerships

UnitedHealthcare (Washington state)Sentara Health Plans (Virginia)

Beyond the preview

Go deeper on Waymark.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Waymark.

Explore the full profile